These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 12710533)
1. Pharmacological characterization of putative beta1-beta2-adrenergic receptor heterodimers. Lavoie C; Hébert TE Can J Physiol Pharmacol; 2003 Feb; 81(2):186-95. PubMed ID: 12710533 [TBL] [Abstract][Full Text] [Related]
2. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility. Zhu WZ; Chakir K; Zhang S; Yang D; Lavoie C; Bouvier M; Hébert TE; Lakatta EG; Cheng H; Xiao RP Circ Res; 2005 Aug; 97(3):244-51. PubMed ID: 16002745 [TBL] [Abstract][Full Text] [Related]
3. Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors. Rousseau G; Nantel F; Bouvier M Mol Pharmacol; 1996 Apr; 49(4):752-60. PubMed ID: 8609905 [TBL] [Abstract][Full Text] [Related]
4. Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors. Suzuki T; Nantel F; Bonin H; Valiquette M; Bouvier M J Pharmacol Exp Ther; 1993 Nov; 267(2):785-90. PubMed ID: 7902433 [TBL] [Abstract][Full Text] [Related]
5. Role of specific protein kinase C isoforms in modulation of beta1- and beta2-adrenergic receptors. Guimond J; Mamarbachi AM; Allen BG; Rindt H; Hébert TE Cell Signal; 2005 Jan; 17(1):49-58. PubMed ID: 15451024 [TBL] [Abstract][Full Text] [Related]
6. Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus. Hillman KL; Doze VA; Porter JE J Pharmacol Exp Ther; 2005 Aug; 314(2):561-7. PubMed ID: 15908513 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of alveolar epithelial active Na+ transport is dependent on beta2-adrenergic receptor signaling. Mutlu GM; Dumasius V; Burhop J; McShane PJ; Meng FJ; Welch L; Dumasius A; Mohebahmadi N; Thakuria G; Hardiman K; Matalon S; Hollenberg S; Factor P Circ Res; 2004 Apr; 94(8):1091-100. PubMed ID: 15016730 [TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy. Ahmet I; Krawczyk M; Heller P; Moon C; Lakatta EG; Talan MI Circulation; 2004 Aug; 110(9):1083-90. PubMed ID: 15313944 [TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic receptor subtypes that mediate ractopamine stimulation of lipolysis. Mills SE; Spurlock ME; Smith DJ J Anim Sci; 2003 Mar; 81(3):662-8. PubMed ID: 12661646 [TBL] [Abstract][Full Text] [Related]
11. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors. Uberti MA; Hague C; Oller H; Minneman KP; Hall RA J Pharmacol Exp Ther; 2005 Apr; 313(1):16-23. PubMed ID: 15615865 [TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis]. Shpakov AO; Derkach KV; Uspenskaia ZI; Shpakova EA; Kuznetsova LA; Plesneva SA; Pertseva MN Tsitologiia; 2004; 46(4):317-25. PubMed ID: 15346790 [TBL] [Abstract][Full Text] [Related]
13. Alpha2C-adrenergic receptors exhibit enhanced surface expression and signaling upon association with beta2-adrenergic receptors. Prinster SC; Holmqvist TG; Hall RA J Pharmacol Exp Ther; 2006 Sep; 318(3):974-81. PubMed ID: 16757535 [TBL] [Abstract][Full Text] [Related]
14. beta1- and beta2-adrenoceptor induced synaptic facilitation in rat basolateral amygdala. Abraham PA; Xing G; Zhang L; Yu EZ; Post R; Gamble EH; Li H Brain Res; 2008 May; 1209():65-73. PubMed ID: 18396264 [TBL] [Abstract][Full Text] [Related]
15. In vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac beta1-adrenoceptors: a comparison with xamoterol. Floreani M; Froldi G; Quintieri L; Varani K; Borea PA; Dorigo MT; Dorigo P J Pharmacol Exp Ther; 2005 Dec; 315(3):1386-95. PubMed ID: 16160085 [TBL] [Abstract][Full Text] [Related]
16. Mutagenesis within helix 6 of the human beta1-adrenergic receptor identifies Lysine324 as a residue involved in imparting the high-affinity binding state of agonists. Zeitoun O; Santos NM; Gardner LA; White SW; Bahouth SW Mol Pharmacol; 2006 Sep; 70(3):838-50. PubMed ID: 16760361 [TBL] [Abstract][Full Text] [Related]
17. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts. Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249 [TBL] [Abstract][Full Text] [Related]
18. Identification of a key amino acid of the beta2-adrenergic receptor for high affinity binding of salmeterol. Isogaya M; Yamagiwa Y; Fujita S; Sugimoto Y; Nagao T; Kurose H Mol Pharmacol; 1998 Oct; 54(4):616-22. PubMed ID: 9765503 [TBL] [Abstract][Full Text] [Related]
19. Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy. Galandrin S; Bouvier M Mol Pharmacol; 2006 Nov; 70(5):1575-84. PubMed ID: 16901982 [TBL] [Abstract][Full Text] [Related]